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Abstract
This study investigated the occurrence and characteristics of adverse drug reactions (ADR) in our hospital and provide references for clinical rational drug use.
We collected the 85 case reports of adverse drug reactions in our hospital in 2010 and made retrospective statistical analysis on them. The varieties of anti-infective
drugs used are the most used. It also had the highest proportion of adverse drug reactions; the common symptom of adverse drug reactions is skin and accessory
damage. Adverse drug reactions are affected by many factors, and relevant departments should strengthen ADR monitoring, to reduce or avoid the occurrence of
adverse drug reactions.
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Introduction
Adverse drug reactions (ADR) refer to the harmful reactions unrelated with drug use purposes caused by approved drugs under normal usage and dosage,
including side effects, allergic reactions, toxic reactions, drug dependence, mutation, distortion, canceration, etc. With the continuous and deepened implementation of
ADR monitoring system in our country, ADR incidence continues to increase. In order to improve body physiology, improve the quality of clinical treatment and
reduce medical disputes, ADR monitoring and reporting have become the legal obligations for medical institutions (Jin et al., 2004). With the continuous strengthening
of drug use management, ADR monitoring becomes increasingly important to guaranteeing public drug use safety, and strengthening. ADR monitoring function has
become an important content of the current epidemiological studies on drugs (Zhao et al., 2009). This paper assorts and analyzes the 85 ADR cases in our hospital
reported in 2010 and summarizes the occurrence and characteristics of adverse reactions, providing scientific references for clinical safe, rational effective drug use.
Data and methods: A total of 85 effective reports of ADR were reported by all the Departments in our hospital in 2010. These were collected physicians and
pharmacists who filled in the “Adverse drug reactions report form”, and the overall ADR summary was made after the preliminary analysis and evaluation by clinical
pharmacists.
A retrospective analysis was made on the clinical data of the 85 cases of ADR, to summarize ADR patients’ gender and age distribution, routes of drug
administration and clinical manifestations. Incidence of ADR caused by monotherapy and combination therapy, and ADR treatment outcomes were also analysed.
Results
Gender and ages of the patients with ADR
In the 85 cases of ADR, 34 cases are male (34/85, 40%), 51 cases are female (51/85, 60%), male to female ratio is about 0.67:1, and the incidence of ADR in
females is higher than that in males. The patients are between 6 months – 87 years old, and the population less than 20 years old is mostly pediatric patients (6/22,
27.27%). The age group with the highest ADR incidence is bellow 10 years old (22/85, 25.88%), followed by the age group of above 70 years old (20/85, 23.53%). The
distribution of gender and ages of the patients with ADR is shown in Table 1.
Table 1: Distribution of gender and ages of the patients with ADR
AgeGender
≤10 11~19 20~29 30~39 40~49 50~59 60~69 ≥70
Total
Male 8 2 4 1 3 2 5 9 34
Female 14 6 4 3 4 3 6 11 51
Total 22 8 8 3 7 5 11 20 85
Proportion（%） 25.88 9.41 9.41 4.71 8.24 5.88 12.94 23.53 100
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Family ADR history and past ADR history
In the 85 cases of ADR, 3 cases had family allergic history (3/85, 3.53%), and 48 cases were unknown (46/85, 54.12%); 18 cases had past ADR history (18/85,
21.18%), and 51 cases were unknown (51/85, 60.00%). The relationship between family and past ADR history and ADR is shown in Table 2.
Table 2: Relationship between family and past ADR history and ADR
FamilyADR history n Proportion （%） Past ADR history n Proportion（%）
Y
N
Unclear
Total
3
36
46
85
3.53
42.35
54.12
100.00
Y
N
Unclear
Total
18
16
51
85
21.18
18.82
60.00
100.00
Distribution of drug administration routes causing ADR
The 85 cases of ADR involve a total of 3 drug administration routes, including 73 cases of intravenous infusion (73/85, 85.88%), 8 cases of oral administration
(8/85, 9.41%), 3 cases of intramuscular injection (3/853.53%) and 1 case of external use (1/85, 1.18%). The relationship between different drug administration routes
and ADR is shown in Table 3.
Table 3: Distribution of drug administration routes causing ADR
Drug administration route n Proportion （%）
Intravenous infusion 73 85.88
Oral administration 8 9.41
Intramuscular injection 3 3.53
External use 1 1.18
Total 85 100.00
Relationship between combination therapy and ADR incidence
The 85 cases of ADR include 68 cases of monotherapy (68/85, 80.00%), 17 cases of combination therapy (17/85, 20.00%), and 12 cases involving antimicrobial
drugs (12/85, 14.12%). 16 cases were combination therapy of two drugs (16/85, 18.82%). The ratio of ADR incidence caused by monotherapy to combination therapy
is 4:1.
Drug varieties causing ADR and incidence
We make the classification statistics on the drugs involved by ADR according to the drug classification method of Chinese Pharmacopoeia Commission (Chinese
Pharmacopoeia Commission., 2001). The 85 cases of ADR involve a total of 50 drugs in 12 categories, in which, 65 cases of ADR were caused by antibiotics,
accounting for the largest proportion (65/85, 76.47%), including 1 case of severe allergic shock, and the others were mostly rash and other allergic-like reactions. In the
cases of ADR, the varieties ranked in decreasing order: amoxicillin sulbactam sodium, ceftriaxone and levofloxacin injection.
Prognosis: All the symptoms of ADR relieve or disappear after drug withdrawal or changing/replacing for other treatment, and there was no case report of death.
Discussion
It can be seen from Table 1 that in the 85 cases of ADR in our hospital, the incidence in female is slightly higher than that in male, and they can occur at any age
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group. The proportion in children below 10 years old and elderly above 60 years old is significantly higher than other age groups, which may be related with the
physiological characteristics of the elderly and children (Xie et al., 2004). For the elderly, because of visceral dysfunction, plasma and drug binding capability decreases,
and different renal clearance rates result in different ADR incidence and severity. For children, underdevelopment of systems and organs and incomplete development
of nervous system could be ascribed to the cause of ADR. In the 85 cases of ADR reports, 31 cases were above 60 years old, accounting for 36.47% of the total. The
reasons are that the elderly have many chronic diseases, the frequency and quantity of drug use are higher than the youth and adults, and also the physiological
functions and activities of the systems and drug metabolism capacity in the elderly begin to weaken (Jian et al., 2003). Four reasons make elderly patients prone to
ADR (Xie et al., 2004): (1) With age increases, the organs in the elderly degrade year
Table 4: Drug varieties causing ADR and incidence
Drug variety Generic name ADR n Proportion Proportion of
(trade name) （%） variety（%）
Penicillin antibiotics Amoxicillin sulbactam sodium (Shusalin) (Xie et al.,2004),
nafcillin sodium(Jin et al., 2004), piperacillin and sulbactam
(Baiding) (Zhao et al.,2009)
9 10.59 3 6.00
Cephalosporin
antibiotics
Cefoperazone sulbactam (Sulperazon) (Zhao et al.,2009),
cefpiramide (Tailixin) and cefpiramide (Lixianni) (Chinese
Pharmacopoeia Commission., 2001), Cefaclor dispersible tablets
(Hengyun) (Jin et al., 2004), cefuroxime sodium (Fulexin) (Jin et
al., 2004), cefuroxime sodium (Andeqing) (Zhao et al.,2009),
ceftriaxone (Fanshengshufu) (Xie et al.,2004), cefathiamidine
(Xianlisu) (Jin et al., 2004)
18 21.18 8 16.00
Macrolide antibiotics Azithromycin (Qixian) (Xie et al., 2004), roxithromycin capsule
(Zhao et al.,2009)
6 7.06 2 4.00
Lincosamide
antibiotics
Clindamycin phosphate (Kelinmei) (Chinese Pharmacopoeia
Commission., 2001), clindamycin phosphate (Kaifufei) (Zhao et
al.,2009)
5 5,88 2 4.00
Fluoroquinolone
antibiotics
Gatifloxacin (Haichao) (Xie et al., 2004), gatifloxacin sodium
chloride (Lepai) (Zhao et al.,2009), levofloxacin (Zuoke) (Jian et
al.,2003), levofloxacin (Hengao) (Jin et al., 2004), sparfloxacin
(Libeier) (Jin et al., 2004)
13 15.3 5 10.00
Other antibiotics Vancomycin (Jin et al., 2004), amphotericin B liposome
(Amphotec) (Jin et al., 2004), amphotericin B (Jin et al., 2004),
rifamycin (Lifuxin) (Jin et al., 2004)
4 4,71 4 8.00
Blood system drugs Carbazochrome sodium sulfonate (Jin et al., 2004), granulocyte
stimulating factor (Jiexin) (Jin et al., 2004)
2 2,35 2 4.00
Respiratory system
drugs
Compound methoxyphenamine capsule (Asmeton) (Jin et al.,
2004), aminophylline (Jin et al., 2004)
2 2.35 2 4.00
Cardiovascular
system drugs
Enalapril maleate tablet (Yisu) (Jin et al., 2004), metoprolol
tartrate tablet (metoprolol) (Zhao et al.,2009), amiodarone
hydrochloride injection (Cordarone) (Zhao et al.,2009), fluvastatin
capsule (Lescol) (Jin et al., 2004), valsartan (Suiyue) (Jin et al.,
2004), felodipine tablet (Boyi tablet) (Jin et al., 2004)
8 9.41 6 12.00
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Digestive system
drugs
Mosapride citrate dispersible tablet (Xinluona) (Jin et al., 2004),
trimebutine maleate (Ruijian) (Jin et al., 2004), metoclopramide
hydrochloride injection (Jin et al., 2004)
3 3.53 3 6.00
Analgesic-antipyretic
drugs
Celecoxib (Celebrex) (Jin et al., 2004) 1 1.18 1 2.00
Other drugs Compound water-soluble vitamin (Jin et al., 2004), Shuxuetong
(Jin et al., 2004), Gushukang particles (Jin et al., 2004), Xiyanping
(Zhao et al.,2009), magnesium isoglycyrrhizinate (Jin et al., 2004),
compound meglumine diatrizoate injection (Jin et al., 2004),
sodium aescinate for injection (Zhao et al.,2009), propofol
injection (Jin et al., 2004), lentinan (Jin et al., 2004), fructose
diphosphate injection (Jin et al., 2004), Zhikang capsule (Jin et al.,
2004), Panlongqi tablet (Jin et al., 2004)
14 16.47 12 24.00
Total 12 categories 85 100 50 100.00
by year, and target organs show high sensitivity to drugs, leading to enhanced drug action intensity and prolonged action time; (2) in the elderly, liver and kidney
volume gradually decrease, blood flow relatively decreases, liver and kidney blood flow is only about half of a strong man, its metabolic capacity is very low, the
first-pass effect is gradually weakened, the bioavailability relatively increases, drug metabolism slows down, and drug half-life is relatively prolonged; (3) the elderly
usually have many chronic diseases, concomitant medication is common, and drug interaction and other reasons cause poor medication compliance; (4) because of
weakened body functions in the elderly, the ability to digest and absorb drug orally administrated is low, the volume distribution for target organs of fat-soluble drugs
increases, albumin in plasma reduces, protein binding of the drugs with high protein binding rate drops sharply, and free drug concentration body increases, resulting in
more prone to poisoning and adverse reactions than the youth. Therefore, hospital doctors should choose drugs cautiously according to the special physiological and
pathological characteristics of the elderly, adhere to the principles of rational drug use, regulate clinical drug dosage, achieve individualized and personalized drug
administration, and strengthen department monitoring during drug administration process, so as to effectively reduce the incidence of ADR.
It can be seen from Table 2 that unknown family history and past history account for 54.12% and 60.00% respectively, indicating that a large proportion of
patients did not pay sufficient attention to the family and past ADR history. In daily clinical work in hospital, paying attention to past allergic history or ADR history
will improve drug use safety factor, and emphasize on preventive and protective measures to reduce the risk of drug use.
It can be seen form Table 3 that in the 85 cases of ADR, 73 cases were caused by intravenous administration, indicating that ADR caused by intravenous
administration route is much higher than other routes, because the drug administration route of intravenous infusion is taken as the main treatment method in inpatients.
At intravenous infusion, drugs directly enter human circulation, with fast action and no first-pass effect, the pharmacological effects and adverse reactions are stronger
than oral administration, and many factors induce ADR, including pH value, osmotic pressure, temperature, particulates, creotoxin, etc (Ling et al., 2005). The
requirements of intravenous administration are much higher than other preparations, so improper preparation operation, low preparation quality, inappropriate drug
combination, long-term preparation liquid placing, high impurity content and fast (low) infusion will cause ADR. Therefore, at clinical drug administration, doctors
should strictly ask patient’s medication history, try to minimize intravenous administration, and adopt oral administration or intramuscular injection instead of
intravenous administration if possible (Wang et al., 2009; Zhao et al., 2009). In case of special demand for intravenous administration, drug administration speed should
be controlled, especially for certain stimulant drugs.
Drug combination always causes drug interactions, and more drugs are combined, the higher the incidence of ADR is. Drug combination is an important cause of
ADR, and the combination of antimicrobial drugs with other drugs can induce or aggravate adverse drug reactions (Wu et al., 2010). Therefore, it is suggested to
minimize the drug varieties needed for clinical treatment.
It can be seen from Table 4 that the 85 cases of ADR involve a total of 50 drugs in 12 categories, in which, the most involved is antimicrobial drugs, whether the
varieties of ADR caused or the number the cases rank the first, consistent with the similar domestic report result (Yang et al., 2001). This may be related with gradually
increased frequency and dosage of clinical use of antimicrobial drugs, increased bacterial resistance, non-indicative drug use, drug combination, overdose, long drug
use time, etc. Irrational use of antibiotics not only increases the economic burden of patients, and also increases the incidence of ADR, as well as causes bacterial
resistance, increases associated complications and prolongs the course of disease. Therefore, doctors need focus on the rational use of antibiotics and the scope of
application, and the antibiotics causing ADR are mostly cephalosporins and fluoroquinolones. Cephalosporins have broad antimicrobial spectrum, obvious bactericidal
effects, stable action on β-lactamase, relatively low toxic reactions and good clinical efficacy and are very commonly used in clinical conditions, so the ADR cases are 
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more reported. This should remind us that doctors should pay full attention to ADR caused by cephalosporins. The clinical manifestations are mainly allergic-like
reactions and involve many organs and systems, so clinicians should use antibiotics in strict accordance with the “Guiding principles for clinical use of antibiotics”, and
it is suggested to make skin test when cephalosporins use is indicated, to reduce the incidence of adverse reactions (Jin et al., 2004).
It can be seen from Table 5 that the clinical manifestations of ADR are mostly skin and accessory damage and secondly digestive system and nervous system
damages, however, it is easy to find and diagnose these two reactions in clinical conditions. The incidence of allergic skin reaction is high, but the majority of disease
conditions are mild, and the symptoms will disappear immediately after drug withdrawal or giving antihistamines. In addition, some commonly used drugs in clinical
use, such as traditional Chinese medicine compound, anti-infective drugs, etc, are antigens, easy to cause allergic reactions after entering into body, so as to cause
dermatitis, rash and other symptoms (Zhang et al., 2010).
Conclusion
It is impossible to completely prevent ADR, but it is possible to reduce the incidence of ADR. In clinical drug use, the following can be adopted to reduce the
incidence of ADR: (1) Pay attention to patient’s constitution and past medical history; to be cautious to use drugs in the elderly and children and strictly master the
indications and dosage. (2) Pay attention to drug administration methods and compatibility: to minimize the proportion of intravenous administration and combination
of many drugs. (3) Strengthen the rational use of anti-infective drugs: to reduce or avoid long drug use, many combined drugs and long course of treatment. (4)
Strengthen ADR event reporting and feedback, provide and perfect drug safety data, and avoid or reduce potential ADR.
Adverse drug reaction is very harmful, and it increases medical costs and brings big economic losses, and in severe cases, causes deformity, cancer and mutation
and even endangers the life of patients, therefore, medical care staff must pay high attention to them. Hospital administration departments should pay full attention to
the service functions of clinical pharmacist, and pharmacists should cooperate with physicians to make rational drug use regimens and actively carry out the following
responsibilities in clinical monitoring of ADR: (1) to help doctors find ADR events in time and accurately fill in the relevant reports; (2) to collect and assort ADR
information in the whole hospital in certain period, timely feedback to clinicians, and increase the warning capability for the drugs causing ADR; (3) to monitor drug
use in special populations, such as patients with liver and kidney dysfunction, infants and children, elderly patients and breastfeeding women; (4) to release timely ADR
information to clinical professional journals and improve preventive consciousness to clinical drug-induced diseases.
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